MYX 1.51% $4.71 mayne pharma group limited

Correction, its "phase 2(b) clinical trial", with a "Type-C...

  1. 6,633 Posts.
    lightbulb Created with Sketch. 615
    Correction, its "phase 2(b) clinical trial", with a "Type-C Guidance Meeting" scheduled, which i think is about going to the next stage, but apparently stage4 is the big one that can take many years. So its long way from getting return, a big percentage dont get final approval.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.71
Change
0.070(1.51%)
Mkt cap ! $400.7M
Open High Low Value Volume
$4.67 $4.75 $4.62 $953.1K 203.6K

Buyers (Bids)

No. Vol. Price($)
1 1236 $4.71
 

Sellers (Offers)

Price($) Vol. No.
$4.72 620 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.